Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p-Reference-Cited by-同舟云学术

Hypoxia-Challenged Pancreatic Adenocarcinoma Cell-Derived Exosomal circR3HCC1L Drives Tumor Growth Via Upregulating PKM2 Through Sequestering miR-873-5p

Published:2024-03-25 Issue: Volume: Page:
ISSN:1073-6085
Container-title:Molecular Biotechnology
language:en
Short-container-title:Mol Biotechnol

Author:

Wang Luoluo,Zhou Shuping^ORCID,Ruan Yi,Wu Xiang,Zhang Xueming,Li Yi,Ying Dongjian,Lu Yeting,Tian Yuan,Cheng Gong,Zhang Jing,Lv Kaiji,Zhou Xinhua

Funder

Clinical Research Fund project of Zhejiang Medical Association

Beijing Medical and Health Foundation

Zhejiang Soft Science Research Program

The Project of Zhejiang Province Traditional Chinese Medicine Science and Technology Plan

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12033-024-01091-z.pdf

Reference45 articles.

1. Lu, X., & Kang, Y. (2010). Hypoxia and hypoxia-inducible factors: Master regulators of metastasis. Clinical Cancer Research, 16(24), 5928–5935. https://doi.org/10.1158/1078-0432.ccr-10-1360

2. Ostergaard, L., Tietze, A., Nielsen, T., Drasbek, K. R., Mouridsen, K., Jespersen, S. N., & Horsman, M. R. (2013). The relationship between tumor blood flow, angiogenesis, tumor hypoxia, and aerobic glycolysis. Cancer Research, 73(18), 5618–5624. https://doi.org/10.1158/0008-5472.can-13-0964

3. Yang, M., & Zhang, C. Y. (2021). Diagnostic biomarkers for pancreatic cancer: An update. World Journal of Gastroenterology, 27(45), 7862–7865. https://doi.org/10.3748/wjg.v27.i45.7862

4. Poels, T. T., & Vuijk, F. A. (2021). Molecular targeted positron emission tomography imaging and radionuclide therapy of pancreatic ductal adenocarcinoma. Cancers, 13(24), 6164. https://doi.org/10.3390/cancers13246164

5. Daniel, S. K., Sullivan, K. M., Labadie, K. P., & Pillarisetty, V. G. (2019). Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma. Clinical and Translational Medicine, 8(1), 10. https://doi.org/10.1186/s40169-019-0226-9